Flexible Meta-Regression to assess the shape of the Benzene-Leukemia Exposure-Response curve

Environmental Health Perspectives

Volumn 118, Issue 4, 2010, Pages 526-532

  Vlaanderen, Jelle ^a   Portengen, Lützen ^a   Rothman, Nathaniel ^b   Lan, Qing ^b   Kromhout, Hans ^a   Vermeulen, Roel ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Benzene; Epidemiology; Leukemia; Meta regression; Quantitative risk assessment

Indexed keywords

BENZENE;

ARTICLE; CANCER RISK; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONFIDENCE INTERVAL; ENVIRONMENTAL EXPOSURE; HUMAN; LEUKEMIA; MATHEMATICAL MODEL; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; STRATIFICATION;

BENZENE; HUMANS; LEUKEMIA; OCCUPATIONAL EXPOSURE; REGRESSION ANALYSIS;

EID: 77951670876     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0901127     Document Type: Article

References (52)

1. Atkinson S, Coppock J, Fritschi L, Glass DC, Gibbons C, Gray CN, et al. 2001. Lympho-haematopoietic Cancer and Exposure to Benzene in the Australian Petroleum Industry. Technical Report and Appendices. Monash University and Deakin University. Available: http://www.aip.com.au/pdf/health/case_study.pdf [accessed 2 February 2010].
2. ATSDR (Agency for Toxic Substances and Disease Registry). 2007. Toxicological Profile for Benzene. Available: http://www.atsdr.cdc.gov/toxprofiles/tp3.html [accessed 2 February 2010].
3. Bagnardi V, Zambon A, Quatto P, Corrao G. 2004. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 159(11):1077-1086.
4. Berlin JA, Longnecker MP, Greenland S. 1993. Meta-analysis of epidemiologic dose-response data. Epidemiology 4(3):218-228.
5. Berman DW, Crump KS. 2008. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol 38 (suppl 1):1-47.
6. Bloemen LJ, Youk A, Bradley TD, Bodner KM, Marsh G. 2004. Lymphohaematopoietic cancer risk among chemical workers exposed to benzene. Occup Environ Med 61(3):270-274.
7. Boice JD Jr, McLaughlin JK. 2001. Errors in TCE analysis. Environ Health Perspect 109:A108-A109.
8. Bond GG, McLaren EA, Baldwin CL, Cook RR. 1986. An update of mortality among chemical workers exposed to benzene. Br J Ind Med 43(10):685-691.
9. Capleton AC, Levy LS. 2005. An overview of occupational benzene exposures and occupational exposure limits in Europe and North America. Chem Biol Interact 153-154:43-53.
10. Collins JJ, Ireland B, Buckley CF, Shepperly D. 2003. Lymphohaematopoeitic cancer mortality among workers with benzene exposure. Occup Environ Med 60(9):676-679.
11. Costantini A, Quinn M, Consonni D. 2003. Exposure to benzene and risk of leukemia among shoe factory workers. Scand J Work Environ Health 29(1):51-59.
12. Crump KS. 1996. Risk of benzene-induced leukemia predicted from the Pliofilm cohort. Environ Health Perspect 104 (suppl 6):1437-1441.
13. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188.
14. Glass DC, Gray CN, Jolley DJ, Gibbons C, Sim MR, Fritschi L, et al. 2003. Leukemia risk associated with low-level benzene exposure. Epidemiology 14(5):569-577.
15. Greenland S, Longnecker MP. 1992. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301-1309.
16. Guénel P, Imbernon E, Chevalier A, Crinquand-Calastreng A, Goldberg M. 2002. Leukemia in relation to occupational exposures to benzene and other agents: a case-control study nested in a cohort of gas and electric utility workers. Am J Ind Med 42(2):87-97.
17. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC. 2006. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 163(11):1042-1052.
18. Hayes RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Travis LB, et al. 1997. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J Natl Cancer Inst 89(14):1065-1071.
19. Johnson ES, Langard S, Lin YS. 2007. A critique of benzene exposure in the general population. Sci Total Environ 374(2-3):183-198.
20. Kim S, Vermeulen R, Waidyanatha S, Johnson BA, Lan Q, Rothman N, et al. 2006a. Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. Carcinogenesis 27(4):772-781.
21. Kim S, Vermeulen R, Waidyanatha S, Johnson BA, Lan Q, Smith MT, et al. 2006b. Modeling human metabolism of benzene following occupational and environmental exposures. Cancer Epidemiol Biomarkers Prev 15(11):2246-2252.
22. Lacasse Y, Martin S, Gagné D, Lakhal L. 2009. Dose-response meta-analysis of silica and lung cancer. Cancer Causes Control 20(6):925-933.
23. Lan Q, Vermeulen R, Zhang L, Li G, Rosenberg PS, Alter BP, et al. 2006. Benzene exposure and hematotoxicity [Letter]. Science 312(5776):998-999; doi:10.1126/science.312.5776.998b [Online 19 May 2006].
24. Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, et al. 2004. Hematotoxicity in workers exposed to low levels of benzene. Science 306(5702):1774-1776.
25. McDonald TA. 2001. Public Health Goal for Benzene in Drinking Water. Sacramento:California Environmental Protection Agency, Office of Environmental Health Hazard Assessment.
26. McElvenny DM, Armstrong BG, Järup L, Higgins JP. 2004. Meta-analysis in occupational epidemiology: a review of practice. Occup Med (Lond) 54(5):336-344.
27. NIOSH (National Institute for Occupational Safety and Health). 1976. Revised Recommendation for an Occupational Exposure Standard for Benzene. Available: http://www.cdc.gov/niosh/76-benz.html [accessed 2 February 2010].
28. Paustenbach DJ, Bass RD, Price P. 1993. Benzene toxicity and risk assessment, 1972-1992: implications for future regulation. Environ Health Perspect 101(suppl 6):177-200.
29. Paustenbach DJ, Price PS, Ollison W, Blank C, Jernigan JD, Bass RD, et al. 1992. Reevaluation of benzene exposure for the Pliofilm (rubberworker) cohort (1936-1976). J Toxicol Environ Health 36(3):177-231.
30. Penney J. 1995. Report to the Occupational Disease Panel (Industrial Disease Standards Panel) on Occupational Exposure to Benzene and Leukaemia. Toronto, Canada: Canadian Centre for Occupational Health and Safety. Available: http://www.canoshweb.org/odp/html/rp7.htm [accessed 2 February 2010].
31. Rappaport SM, Kim S, Lan Q, Vermeulen R, Waidyanatha S, Zhang L, et al. 2009. Humans activate benzene via two metabolic pathways. Environ Health Perspect 117:946-952.
32. Rappaport SM, Waidyanatha S, Qu Q, Shore R, Jin X, Cohen B, et al. 2002a. Albumin adducts of benzene oxide and 1,4-benzoquinone as measures of human benzene metabolism. Cancer Res 62(5):1330-1337.
33. Rappaport SM, Waidyanatha S, Yeowell-O'Connell K, Rothman N, Smith MT, Zhang L, et al. 2005. Protein adducts as biomarkers of human benzene metabolism. Chem Biol Interact 153-154:103-109.
34. Rappaport SM, Yeowell-O'Connell K, Smith MT, Dosemeci M, Hayes RB, Zhang L, et al. 2002b. Non-linear production of benzene oxide-albumin adducts with human exposure to benzene. J Chromatogr B Analyt Technol Biomed Life Sci 778(1-2):367-374.
35. Rinsky RA, Hornung RW, Silver SR, Tseng CY. 2002. Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment. Am J Ind Med 42(6):474-480.
36. Rinsky RA, Smith AB, Hornung R, Filloon TG, Young RJ, Okun AH, et al. 1987. Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med 316(17):1044-1050.
37. Rothman KJ, Boice JD, Austin H. 1982. Epidemiologic Analysis with a Programmable Calculator. Boston, MA:Epidemiology Resources.
38. Rothman N, Bechtold WE, Yin SN, Dosemeci M, Li GL, Wang YZ, et al. 1998. Urinary excretion of phenol, catechol, hydroquinone, and muconic acid by workers occupationally exposed to benzene. Occup Environ Med 55(10):705-711.
39. Rushton L, Romaniuk H. 1997. A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med 54(3):152-166.
40. Schnatter AR, Armstrong TW, Nicolich MJ, Thompson FS, Katz AM, Huebner WW, et al. 1996. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ Med 53(11):773-781.
41. Schnatter AR, Rosamilia K, Wojcik NC. 2005. Review of the literature on benzene exposure and leukemia subtypes. Chem Biol Interact 153-154:9-21.
42. Shi JQ, Copas JB. 2004. Meta-analysis for trend estimation. Stat Med 23(1):3-19, 159-162.
43. Stayner L, Steenland K, Dosemeci M, Hertz-Picciotto I. 2003. Attenuation of exposure-response curves in occupational cohort studies at high exposure levels. Scand J Work Environ Health 29(4):317-324.
44. Steinmaus C, Smith AH, Jones RM, Smith MT. 2008. Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup Environ Med 65(6):371-378.
45. Swaen GM, Scheffers T, de Cock J, Slangen J, Drooge H. 2005. Leukemia risk in caprolactam workers exposed to benzene. Ann Epidemiol 15(1):21-28.
46. U.S. Environmental Protection Agency. 1998. Carcinogenic Effects of Benzene: An Update. EPA/600/P-97/001F. Washington, DC:U.S. Environmental Protection Agency.
47. Vlaanderen J, Vermeulen R, Heederik D, Kromhout H. 2008. Guidelines to evaluate human observational studies for quantitative risk assessment. Environ Health Perspect 116(12):1700-1705.
48. Wartenberg D, Reyner D, Scott CS. 2000. Trichloroethylene and cancer: epidemiologic evidence. Environ Health Perspect 108(suppl 2):161-176.
49. Wong O. 1987. An industry wide mortality study of chemical workers occupationally exposed to benzene. II. Dose response analyses. Br J Ind Med 44(6):382-395.
50. WHO. 1967. International Classification of Diseases (ICD), Eighth revision. Geneva:World Health Organization.
51. WHO. 1977. International Classification of Diseases (ICD), Ninth revision. Geneva:World Health Organization.
52. Zeeb H, Blettner M. 1998. Adult leukaemia: what is the role of currently known risk factors? Radiat Environ Biophys 36(4):217-228.